arrow
D

David A. Scheiblin

nih national cancer institute
H指数:12
被引数:635

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

3′UTR-directed, kinase-proximal mRNA decay inhibits C/EBPβ phosphorylation/activation to suppress senescence in tumor cells

3′UTR介导的、激酶邻近的mRNA降解抑制C/EBPβ磷酸化/活化以抑制肿瘤细胞衰老

2026-08-010
OA
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density

系统性Nos2耗竭和Cox抑制限制了TNBC疾病的进展,并改变了淋巴样细胞的空间方向和密度

2022-12-0110
OA
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer

肿瘤照射联合血管靶向光动力疗法可增强临床前前列腺癌的抗肿瘤作用

2021-06-2110
OAAI
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model

anti-PD-L1免疫治疗联合放疗对小鼠前列腺癌模型肿瘤免疫微环境的影响

2020-07-0960
OAAI
Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level

诱导型一氧化氮合酶衍生的细胞外一氧化氮通量在单细胞水平调节促炎反应

2020-01-0138
OAAI
Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer

NOS2和COX2的共表达可加速肿瘤生长并降低雌激素受体阴性乳腺癌的生存率

2017-10-2785
OAAI